ULIHF Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (6 Dec 2023 @ 09:39):

The United Laboratories International Holdings Limited, an investment holding company, engages in the research, development, manufacture, distribution, and sale of pharmaceutical products...

Stats
Today's Volume	100.00
Average Volume	0.00
Market Cap	1.62B
Next earnings date	( $0 ) 2024-06-19
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	5.26
ATR14	$0.00400 (0.45%)

Volume Correlation

Long: 0.05 (neutral)

Short: 0.00 (neutral)

Signal:(99.078) Neutral

The United Laboratories Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

The United Laboratories Correlation - Currency/Commodity

0.22
( neutral )

0.39
( neutral )

0.00
( neutral )

-0.70
( moderate negative )

-0.13
( neutral )

The United Laboratories Financials

Annual	2023
Revenue:	$13.74B
Gross Profit:	$6.33B (46.11 %)
EPS:	$1.490

FY	2023
Revenue:	$13.74B
Gross Profit:	$6.33B (46.11 %)
EPS:	$1.490

FY	2022
Revenue:	$11.33B
Gross Profit:	$4.97B (43.84 %)
EPS:	$0.870

Financial Reports:

No articles found.

The United Laboratories

The United Laboratories International Holdings Limited, an investment holding company, engages in the research, development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers oral antibiotics, antimicrobials for injection, anti-cold products, cough medicines, ophthalmic drugs, antiviral drugs, anti-hepatitis B drugs, diabetes drugs, skin drugs for external use, cardiovascular and cerebrovascular drugs, nervous system drugs, vitamins, and vacant gelatin capsules, as well as API and intermediate products. It also manufactures and sells soft capsules casings; holds trademarks; and trades in pharmaceutical products. In addition, the company provides management services. It has operations in the People's Republic of China, Europe, India, the Middle East, South America, other Asian regions, and internationally. The company was founded in 1990 and is headquartered in Yuen Long, Hong Kong.